AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: XTANDI (Astellas Pharma Inc.) (xtandi.com)
This is a high-integrity medical website that prioritizes regulatory transparency over marketing hyperbole. The BS score of 11 reflects a site that provides substantial evidence for every claim, with only minor points lost to necessary repetition and standard patient-engagement terminology. It is an authoritative resource for both patients and healthcare providers.
Incorporate National Clinical Trial (NCT) identifiers into each clinical results section to allow for one-click verification of raw data on government registries. Replace marketing-heavy headings like ‘Real XTANDI Xperiences’ with ‘Patient Case Study Videos’ to better align with the clinical tone of the rest of the site. Include specific peer-reviewed journal citations (e.g., NEJM or Lancet) next to the 5-year survival statistics. Add a technical glossary explaining the statistical difference between ‘median’ and ‘average’ to further empower high-literacy patients and reduce perceived ambiguity.
The site exhibits high information density, particularly on the clinical-trials page, which avoids fluff headings in favor of substance-led markers like ‘XTANDI slowed disease progression.’ The body substance ratio is exceptionally high, citing specific patient counts (e.g., ‘154 out of 574 deaths’) and median survival deltas (e.g., ’35 months vs 31 months’). Information Density points were primarily triggered by the repetition of the ‘4 types’ value proposition, which appears in H1s, meta descriptions, and body text across all four analyzed pages. A minor penalty was applied for heading fluff in the patient experience sections, such as ‘The Power of Support.’
AI does not consolidate duplicates — it embeds whatever it crawls. Generate your URL & Canonical Hygiene Audit to quantify the identity conflicts that break your semantic cohesion.
There is zero semantic drift between the homepage signal and the sub-page substance. The homepage H1 claims approval for 4 types of advanced prostate cancer, and the Clinical Results page provides dedicated, granular data sections for all four (mCSPC, mCRPC, nmCRPC, and nmCSPC). Messaging regarding financial support and the Doctor Discussion Guide is consistently maintained across the site’s hierarchy without contradiction.
Transition from a collection of strings to a machine verifiable identity. Generate your Clinical SEO Strategy to establish a robust Knowledge Graph Topology and eliminate semantic black holes.
Trust theatre is minimal but present in the ‘Real XTANDI Xperiences’ sections, where review_count values of 3 and 2 are noted in the data without verified external proof_links_count. However, this is significantly offset by the site’s primary proof paths: the full Prescribing Information PDF and the rigorous ‘Select Safety Information’ blocks that provide a balanced view of risks. The site avoids the ‘Claims without evidence’ trap by grounding every efficacy percentage in a specific trial cohort.
The proof density is high, with the site providing specific clinical trial data for every major efficacy claim. The ratio of verifiable evidence to marketing fluff is approximately 8:1, with nearly every H4 and H5 heading on the clinical page serving as a data delivery mechanism rather than a vague assertion.
For a high volume editorial domain example, open the Search Engine Journal Semantic HTML audit. View the SEJ Semantic HTML Audit to see how template drift and structural noise impact AI chunking.
The site uses several industry clichés and template fingerprints, including ‘FDA approved,’ ‘clinical trial data,’ and ‘Patient Resources.’ These matches (6 total) resulted in a minor 3-point penalty for generic industry language. However, the value proposition is clearly differentiated and cannot be simply copy-pasted onto competitors due to the specific regulatory indication for four distinct stages of prostate cancer.
No authority gaps were detected. The manufacturer (Astellas) is clearly identified in the footer and structured data, and the drug is identified by its non-proprietary name (enzalutamide). The site does not rely on unverifiable ‘expert’ endorsements but instead points users toward their own healthcare professionals via the Doctor Discussion Guide.
There is no disconnect between marketing claims and clinical performance. Bold assertions like ‘61% less risk of cancer progression’ are immediately followed by raw trial numbers (89 out of 576 patients) and a clear definition of how progression was measured (scans or death). This level of transparency is characteristic of compliant pharmaceutical communications.
Medical Devices, Pharma & Biotech BS: XTANDI (Astellas Pharma Inc.) (xtandi.com)
The website perfectly aligns with the Pharmaceutical and Biotech industry, specifically within the oncology therapeutic area. The presence of extensive Important Safety Information (ISI), clinical trial data sets, and regulatory approval claims confirms its classification.
Every pillar of machine readability depends on one foundation: explicit, verifiable entity definitions. Explore the Structured Data Technical Framework to understand how identity, relationships, and @id anchors form the base layer of AI interpretation.
“The BS score was driven by Pillar 1 (Information Density) due to the high repetition of the core regulatory claim and Pillar 4 (Commodity Fingerprint) due to the use of standard pharmaceutical marketing jargon. Pillar 3 (Trust and Proof) contributed 2 points because the patient stories lack verified external proof links, despite the high quality of the surrounding clinical data.”
Analysis Disclosure & Source Attribution
Snapshot Date: June 20, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at XTANDI (Astellas Pharma Inc.) to view the most current version of their content and see directly what the company offers.